Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures: 2016-2025

Historic Capital Expenditures for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to $2,804.

  • cbdMD's Capital Expenditures fell 71.96% to $2,804 in Q3 2025 from the same period last year, while for Sep 2025 it was $184,172, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $184,172 for FY2025, which is 3.08% down from last year.
  • cbdMD's Capital Expenditures amounted to $2,804 in Q3 2025, which was up 90.10% from $1,475 recorded in Q2 2025.
  • cbdMD's Capital Expenditures' 5-year high stood at $231,030 during Q4 2021, with a 5-year trough of -$102,390 in Q1 2023.
  • For the 3-year period, cbdMD's Capital Expenditures averaged around $49,437, with its median value being $12,753 (2024).
  • In the last 5 years, cbdMD's Capital Expenditures spiked by 643.93% in 2022 and then tumbled by 171.72% in 2023.
  • Quarterly analysis of 5 years shows cbdMD's Capital Expenditures stood at $231,030 in 2021, then fell by 23.23% to $177,370 in 2022, then rose by 4.10% to $184,635 in 2023, then declined by 10.97% to $164,387 in 2024, then crashed by 71.96% to $2,804 in 2025.
  • Its last three reported values are $2,804 in Q3 2025, $1,475 for Q2 2025, and $15,506 during Q1 2025.